Nguyen, T.-H., Limpens, M., Bouhmidi, S., Paprzycki, L., Legrand, A., Decleves, A.-E., Heher, P., Belayew, A., Banerji, C., Zammit, P., & Tassin, A. (26 April 2024). Hypoxia and Hypoxia-Inducible Factor Signaling in Muscular Dystrophies [Paper presentation]. Physphar Spring Meeting 2024 - Closing lecture. ![]() |
![]() ![]() | Paprzycki, L., Gourari, Y., Legrand, A., Debacq-Chainiaux, F., & Tassin, A. (April 2024). Effect of Episodic Hypoxaemia on skeletal muscle: which association with ApN pathway modifications? [Poster presentation]. 8th International Congress Myology, Paris, France. ![]() |
![]() ![]() | Nguyen, T. H., Limpens, M., Bouhmidi, S., Paprzycki, L., Legrand, A., Decleves, A.-E., Heher, P., Belayew, A., Banerji, C. R. S., Zammit, P. S., & Tassin, A. (15 March 2024). The DUX4-HIF1α Axis in Murine and Human Muscle Cells: A Link More Complex Than Expected. International Journal of Molecular Sciences, 25 (332). doi:10.20944/preprints202211.0532.v2 ![]() ![]() |
![]() ![]() | Nguyen, T.-H., Paprzycki, L., Legrand, A., Decleves, A.-E., Heher, P., Limpens, M., Belayew, A., Banerji, C. R. S., Zammit, P. S., & Tassin, A. (16 December 2023). Hypoxia enhances human myoblast differentiation: involvement of HIF1α and impact of DUX4, the FSHD causal gene. Skeletal Muscle, 13 (1), 21. doi:10.1186/s13395-023-00330-2 ![]() |
![]() ![]() | Paprzycki, L., Gourari, Y., Legrand, A., DEBACQ-CHAINIAUX, F., & Tassin, A. (24 November 2023). Effect of Episodic Hypoxaemia on skeletal muscle: which association with Ad pathway modifications? [Poster presentation]. PhyPhar Autumn Meeting. |
![]() ![]() | Paprzycki, L., Gourari, Y., Legrand, A., Debacq-Chainiaux, F., & Tassin, A. (28 April 2023). Sustained Intermittent hypoxaemia as a component of COPD pathophysiology: which effect on skeletal muscle? [Paper presentation]. BELGIAN SOCIETY OF PHYSIOLOGY AND PHARMACOLOGY Spring Meeting 2023, Bruxelles, Belgium. ![]() |